Search results
MannKind (MNKD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 days agoImage source: The Motley Fool. MannKind (NASDAQ: MNKD) Q1 2024 Earnings Call May 08, 2024, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers...
MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoMannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript November 7, 2023 MannKind...
Why Shares of MannKind Are Up Wednesday
Motley Fool· 1 year agoShares of MannKind (NASDAQ: MNKD) were up 15.6% Wednesday morning after the company released first-quarter earnings after the market closed on Tuesday....
3 Biotech Stocks Under $15 Worth a Second Look in 2023
Motley Fool· 1 year agoNovavax stands out with its more traditional, protein-based COVID-19 vaccine; MannKind is making a...
MannKind Corp (MNKD) Reports Substantial Revenue Growth in 2023
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenues: $199M in 2023, a 99% increase compared to $99.77M in 2022. Fourth Quarter Revenues: $58M in Q4 2023, up 62% from $36.06M in Q4 2022. Net Income: Achieved a net income of $1M ...
MannKind Corp (MNKD) Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...
GuruFocus.com via Yahoo Finance· 6 days agoRevenue Growth: Increased by 63% year-over-year in Q1 2024. Net Income: Reported at $11 million in Q1 2024. Earnings Per Share (EPS): Achieved $0.04 in Q1 2024. Cash Position: Ended Q1 with ...
Q2 2023 MannKind Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 months agoParticipants Michael E. Castagna; CEO & Director; MannKind Corporation Steven B. Binder; CFO; MannKind Corporation Anthony Charles Petrone; MD of Senior Medical Devices, Diagnostics & Therapeutics ...
Why Shares of MannKind Corporation Climbed 10.4% on Monday
Motley Fool· 2 years agoWhat happened Shares of MannKind Corporation (NASDAQ: MNKD), a biotech company that specializes in finding therapies for endocrine and orphan lung diseases, rose 10.4% on Monday. The stock closed at $3.
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
InvestorPlace via Yahoo Finance· 10 months agoThe tech and growth segments of the market have been having a tremendous 2023 with one glaring...
3 Biotech Stocks to Avoid Like the Plague
InvestorPlace via Yahoo Finance· 12 months agoBiotech stocks have gotten caught up in the broader technology sector sell-off. The benchmark iShares Biotechnology ETF (NYSEARCA:IBB) has fallen from a...